Bouchalova, P.; Beranek, J.; Lapcik, P.; Potesil, D.; Podhorec, J.; Poprach, A.; Bouchal, P.
Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment. Biomedicines 2021, 9, 1145.
https://doi.org/10.3390/biomedicines9091145
AMA Style
Bouchalova P, Beranek J, Lapcik P, Potesil D, Podhorec J, Poprach A, Bouchal P.
Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment. Biomedicines. 2021; 9(9):1145.
https://doi.org/10.3390/biomedicines9091145
Chicago/Turabian Style
Bouchalova, Pavla, Jindrich Beranek, Petr Lapcik, David Potesil, Jan Podhorec, Alexandr Poprach, and Pavel Bouchal.
2021. "Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment" Biomedicines 9, no. 9: 1145.
https://doi.org/10.3390/biomedicines9091145
APA Style
Bouchalova, P., Beranek, J., Lapcik, P., Potesil, D., Podhorec, J., Poprach, A., & Bouchal, P.
(2021). Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment. Biomedicines, 9(9), 1145.
https://doi.org/10.3390/biomedicines9091145